[1. Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis. 2005; 12(4): 353-365.10.1053/j.ackd.2005.07.01116198274]Search in Google Scholar
[2. Zolezzi M. Management of dyslipidemia in renal disease and transplantation. Saudi J Kidney Dis Transpl. 2006; 17(2): 129-136.]Search in Google Scholar
[3. Eikmans M, Aben JA, Koop K, Baelde HJ, de Heer E, Bruijn JA. Genetic factors in progressive renal disease: the good ones, the bad ones and the ugly ducklings. Nephrol Dial Transpl. 2006; 21(2): 257-260.10.1093/ndt/gfi32516330465]Search in Google Scholar
[4. Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal disease. Kidney Int Suppl. 2005 (94): S46-S49.10.1111/j.1523-1755.2005.09411.x15752239]Search in Google Scholar
[5. Braun A, Kammerer S, Bohme E, Muller B, Roscher AA. Identification of polymorphic sites of the human bradykinin B2 receptor gene. Biochem Biophys Res Commun. 1995; 211(1): 234-240.10.1006/bbrc.1995.18017779090]Search in Google Scholar
[6. Nagase S, Suzuki H, Wang Y, Kikuchi S, Hirayama A, Ueda A, et al. Association of eNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem. 2003; 244(1-2): 113-118.10.1007/978-1-4615-0247-0_16]Search in Google Scholar
[7. Yun Z, Yu-Ping Y, Zong-Wu T, Yang S, Fang Y, Fang S. Association of endothelial nitric oxide synthase gene polymorphisms with end-stage renal disease: a systematic review and metaanalysis. Ren Fail. 2014; 36(6): 987-993.10.3109/0886022X.2014.90060124673298]Search in Google Scholar
[8. Zychma MJ, Gumprecht J, Trautsolt W, Szydlowska I, Grzeszczak W. Polymorphic genes for kinin receptors, nephropathy and blood pressure in type 2 diabetic patients. Am J Nephrol. 2003; 23(2): 112-116.10.1159/00006803512481150]Search in Google Scholar
[9. Zhou TB, Yin SS. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease. Ren Fail. 2013; 35(4): 573-578.10.3109/0886022X.2013.77383423464568]Search in Google Scholar
[10. Maltais I, Bachvarova M, Maheux P, Perron P, Marceau F, Bachvarov D. Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/ creatinine values in diabetic patients. Can J Physiol Pharmacol. 2002; 80(4): 323-327.10.1139/y02-03612025967]Search in Google Scholar
[11. Buraczynska M, Ksiazek P, Zaluska W, Nowicka T, Ksiazek A. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol Dial Transpl. 2004; 19(9): 2302-2306.10.1093/ndt/gfh07715299097]Search in Google Scholar
[12. Bachvarov DR, Landry M, Pelletier I, Chevrette M, Betard C, Houde I, et al. Characterization of two polymorphic sites in the human kinin B1 receptor gene: altered frequency of an allele in patients with a history of end-stage renal failure. J Am Soc Nephrol. 1998; 9(4): 598-604.10.1681/ASN.V945989555662]Search in Google Scholar
[13. Tang FY, Liu FY, Xie XW. Association of angiotensin- converting enzyme and endothelial nitric oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population. Mol Cell Biochem. 2008;319(1-2):33-9.10.1007/s11010-008-9874-618629615]Search in Google Scholar
[14. Li J, Cun Y, Tang WR, Wang Y, Li SN, Ouyang HR, et al. Association of eNOS gene polymorphisms with essential hypertension in the Han population in southwestern China. Genet Molec Res. 2011; 10(3): 2202-2212.10.4238/vol10-3gmr116021968727]Search in Google Scholar